| Entity | Document Type | Tax ID |
|---|---|---|
| Lupus Research Alliance | Consolidated Audited Financial Statements | Multiple |
| Lupus Research Alliance | IRS Form 990 | 58-2492929 |
|
Entity: Lupus Research Alliance Document Type: Consolidated Audited Financial Statements Tax ID: Multiple |
|
Entity: Lupus Research Alliance Document Type: IRS Form 990 Tax ID: 58-2492929 |
| Name | Title | Compensation | |
|---|---|---|---|
| 1 | Albert Roy | CEO / President | $522,768 |
| 2 | Teodora Staeva | VP / Chief Scientific Officer | $408,297 |
| 3 | Kenneth M. Faber | Past CEO / President | $400,000 |
|
1 Name: Albert Roy Title: CEO / President Compensation: $522,768 |
|
2 Name: Teodora Staeva Title: VP / Chief Scientific Officer Compensation: $408,297 |
|
3 Name: Kenneth M. Faber Title: Past CEO / President Compensation: $400,000 |
According to the Lupus Research Alliance consolidated audit of December 31, 2023 (Note 1, Organization): "...During the year ended December 31, 2023, the Alliance received approximately 74% of its contributions from one foundation..." |
According to the Lupus Research Alliance consolidated audit of December 31, 2023 (Note 6, Investments), the Alliance reports having total investments with a fair value of $81,768,889 and $86,853,912 at December 31, 2023 and 2022, respectively. "...At December 31, 2023 and 2022, approximately 46% and 49%, respectively, of total investments was invested in one Fortune 500 company..." |
According to the Lupus Research Alliance consolidated audit of December 31, 2023 (Note 13, Commitment): "As of December 31, 2023, the Alliance has commitments of approximately $14,505,000 for consulting services through October 31, 2031. Approximately $12,775,000 of the total commitments are related to the Alliance's Lupus Nexus Project." |
According to the Lupus Research Alliance consolidated audit of December 31, 2023 (Note 15, Employee Retention Tax Credit): "The Coronavirus Aid, Relief and Economic Security ('CARES') Act enacted in 2020 allowed eligible employers to claim employee retention tax credits for qualified wages paid after March 12, 2020 and before September 30, 2021. The Alliance qualified for the credit during this period based on partial suspension due to government COVID-related orders and a decrease in gross receipts. The amount of the credit claimed by the Alliance during 2023 and 2022 was $334,880 and $294,339, respectively." |
According to the Lupus Research Alliance (LRA) 2023 tax filing, LRA reports re: Compensation, Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (IRS Form 990, Schedule J, Part II): LRA reports "Bonus & incentive compensation" payments to 9 individuals in 2023, including $70,000 paid to Albert Roy, President & CEO. The reported total compensation in 2023 for Albert Roy is $522,768. The remaining eight individuals received "Bonus & incentive compensation" that ranged from $10,000 to $50,000, with associated reported total compensation in 2023 ranging from $201,002 to $408,297 (IRS Form 990, Schedule J, Part II). |
According to the Lupus Research Alliance (LRA) tax filing for the fiscal year ended December 31, 2023, LRA reports re: Supplemental Information to Form 990 or 990-EZ (IRS Form 990, Schedule O): Regarding family or business relationships among officers, directors, trustees, or key employees (IRS Form 990, Part VI, Section A, Line 2): "Ira Akselrad and Robert Wood Johnson, IV (past Chairman of the Board), have a business relationship. Richard K. Descherer (Co-Chair) and Jennie Descherer have a family relationship." [Jennie Descherer is reported to be a Director (IRS Form 990, Part VII, Column A)]. |
